Zivo Bioscience | 10-K: Annual report
Zivo Bioscience | SCHEDULE 13D/A: Others
Zivo Bioscience | 8-K: Current report
Zivo Bioscience | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Zivo Bioscience | SC 13D: Statement of acquisition of beneficial ownership by individuals-Christopher D. Maggiore(12.8%)
Zivo Bioscience | 8-K: Current report
Zivo Bioscience | 8-K: Current report
Zivo Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Cornell Alison A
Zivo Bioscience | 8-K: Current report
Zivo Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Maggiore Christopher D.
Zivo Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Maggiore Christopher D.
Zivo Bioscience | 8-K: Current report
Zivo Bioscience | RW: Registration Withdrawal Request
Zivo Bioscience | 8-K: Current report
Zivo Bioscience | 8-K: Current report
Zivo Bioscience: Q3 2023 Earnings Report
Zivo Bioscience | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Zivo Bioscience | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Zivo Bioscience | 4: Statement of changes in beneficial ownership of securities-10% Owner STROME MARK E
Zivo Bioscience | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mark E. Strome(5.3%),Strome Mezzanine Fund, LP(3.3%), etc.
No Data